A clinical trial to study the effect of a formulation prepered from Shatavari and other drugs and milk in the management of garbhakshaya (restricted fetal growth in womb)
Phase 4
Completed
- Conditions
- Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2019/02/017611
- Lead Sponsor
- IPGTRA through department of Ayush Government of India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Women with known LMP.
2.Singleton pregnancy with gestational age above 30
3.Age group of 20-37 years.
4.All kinds of IUGR are included.
5.IUGR associated with oligohydramnios (AFI <8cm), Anemia (Hb <11g/dL and more than 8g/dL),mild PIH (BP upto 140/90mmHg, Proteinuria upto 0.3g/L)
Exclusion Criteria
1.Congenital anomalies of foetus.
2.Pregnancy complicated with gestational diabetes, hypertension, renal diseases, Abruptio placenta, Placenta previa, PET, Eclampsia.
3.Multiple pregnancy
4.Systemic diseases like diabetes mellitus, hypertension (BP >140/90mmHg), HIV, severe forms of cardio vascular diseases, infective TB, hepatitis B etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EfficacyTimepoint: Ten days
- Secondary Outcome Measures
Name Time Method SafetyTimepoint: Ten days